e-learning
resources
Virtual 2021
05.09.2021
COVID - 19: lessons learned
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of pharmacological therapies in hospitalized COVID-19 patients– A literature review
E. Han (Collegeville, United States of America), E. Lu (Collegeville, United States of America), A. Heyes (Manchester, United Kingdom), J. Mauskopf (North Carolina, United States of America), H. Birch (Brentford, United Kingdom), M. Bracher (Stevanage, United Kingdom), E. Han (Collegeville, United States of America)
Source:
Virtual Congress 2021 – COVID - 19: lessons learned
Session:
COVID - 19: lessons learned
Session type:
E-poster
Number:
523
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Han (Collegeville, United States of America), E. Lu (Collegeville, United States of America), A. Heyes (Manchester, United Kingdom), J. Mauskopf (North Carolina, United States of America), H. Birch (Brentford, United Kingdom), M. Bracher (Stevanage, United Kingdom), E. Han (Collegeville, United States of America). The use of pharmacological therapies in hospitalized COVID-19 patients– A literature review. 523
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Current evidence for COVID-19 therapies: a systematic literature review
Source: Eur Respir Rev, 30 (159) 200384; 10.1183/16000617.0384-2020
Year: 2021
The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisyA systematic review and meta-analysis
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
A systematic review and meta-analysis of complementary and alternative medicine in asthma
Source: Eur Respir Rev 2017; 26: 160092
Year: 2017
The safety of cardioselective ß
1
-blockers in asthma: literature review and search of global pharmacovigilance safety reports
Source: ERJ Open Res, 7 (1) 00801-2020; 10.1183/23120541.00801-2020
Year: 2021
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018
Year: 2019
As needed therapies in mild to severe asthma: a systematic review and network meta-analysis
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Outpatient management of community acquired pneumonia using severity prediction tools: A systematic review and meta-analysis
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis
Source: Eur Respir J 2013; 42: 721-732
Year: 2013
Prevalence of nonadherence to controller therapy in adults with severe asthma – a systematic review and meta-analysis
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Clinical effectiveness and models of pulmonary rehabilitation in low-resource-settings: a systematic review
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
Contents of nurse-led interventions for the promotion of self-management in COPD patients: a systematic literature review
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis
Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020
Year: 2021
State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advances
Source: Eur Respir Rev, 27 (148) 170139; 10.1183/16000617.0139-2017
Year: 2018
Efficacy of acupuncture in asthma: systematic review and meta-analysis of published data from 11 randomised controlled trials
Source: Eur Respir J 2002; 20: 846-852
Year: 2002
Systematic review and MAIC of OCS reduction with biologic asthma treatments
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept